Mizuho Cuts GE HealthCare Technologies (NASDAQ:GEHC) Price Target to $105.00

GE HealthCare Technologies (NASDAQ:GEHC) had its target price trimmed by Mizuho from $110.00 to $105.00 in a report issued on Wednesday morning, Benzinga reports. The firm currently has a buy rating on the stock.

Several other research analysts have also issued reports on the stock. Citigroup raised their price target on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a buy rating in a report on Wednesday, April 3rd. Argus lifted their price objective on GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a buy rating in a research report on Monday, April 1st. Morgan Stanley lifted their target price on GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an equal weight rating in a report on Monday, February 12th. Evercore ISI increased their price target on GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an outperform rating in a report on Thursday, April 4th. Finally, UBS Group raised shares of GE HealthCare Technologies from a sell rating to a neutral rating and raised their price objective for the stock from $66.00 to $88.00 in a research report on Monday, February 12th. Four analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of Moderate Buy and an average price target of $95.00.

GE HealthCare Technologies Price Performance

Shares of NASDAQ:GEHC opened at $79.47 on Wednesday. The company has a debt-to-equity ratio of 1.11, a quick ratio of 0.83 and a current ratio of 1.06. GE HealthCare Technologies has a 52 week low of $62.35 and a 52 week high of $94.50. The firm has a market cap of $36.27 billion, a PE ratio of 22.76, a price-to-earnings-growth ratio of 2.72 and a beta of 1.26. The firm’s fifty day moving average is $88.44 and its 200-day moving average is $78.81.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Tuesday, April 30th. The company reported $0.90 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.90. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. The business had revenue of $4.65 billion during the quarter, compared to analyst estimates of $4.80 billion. During the same period last year, the company earned $0.85 EPS. GE HealthCare Technologies’s revenue for the quarter was down 1.2% compared to the same quarter last year. Sell-side analysts predict that GE HealthCare Technologies will post 4.3 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be given a dividend of $0.03 per share. The ex-dividend date is Thursday, April 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.15%. GE HealthCare Technologies’s payout ratio is 3.51%.

Insider Activity at GE HealthCare Technologies

In other news, insider Frank R. Jimenez bought 1,315 shares of GE HealthCare Technologies stock in a transaction dated Wednesday, May 1st. The stock was purchased at an average price of $76.52 per share, for a total transaction of $100,623.80. Following the purchase, the insider now directly owns 75,796 shares in the company, valued at approximately $5,799,909.92. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.27% of the stock is currently owned by insiders.

Institutional Investors Weigh In On GE HealthCare Technologies

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Wynn Capital LLC lifted its holdings in GE HealthCare Technologies by 4.1% during the first quarter. Wynn Capital LLC now owns 3,125 shares of the company’s stock worth $284,000 after acquiring an additional 122 shares during the period. Byrne Asset Management LLC raised its stake in shares of GE HealthCare Technologies by 0.8% during the 1st quarter. Byrne Asset Management LLC now owns 16,424 shares of the company’s stock worth $1,493,000 after purchasing an additional 126 shares during the period. WASHINGTON TRUST Co grew its position in GE HealthCare Technologies by 7.7% during the first quarter. WASHINGTON TRUST Co now owns 1,853 shares of the company’s stock valued at $168,000 after buying an additional 133 shares during the period. Fiduciary Trust Co increased its holdings in GE HealthCare Technologies by 1.8% during the fourth quarter. Fiduciary Trust Co now owns 7,696 shares of the company’s stock worth $595,000 after buying an additional 133 shares during the last quarter. Finally, Quent Capital LLC increased its holdings in GE HealthCare Technologies by 21.3% during the first quarter. Quent Capital LLC now owns 780 shares of the company’s stock worth $71,000 after buying an additional 137 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.